Yangtze River Pharmaceutical Group (Hereinafter refers to as YRPG) founded in 1971, is a national large scale medical industrial association in China, trans-regional, with production-teaching-research cooperation, unification of scientific industrial & trading, which is named as the first group of Innovative Enterprise by the Ministry of Science and Technology. The headquarters of YRPG is located in Taizhou city of Jiangsu province covering more than 2 million square meters, with over 8000 employees, and total assets nearly RMB 10 billion. YRPG has more than 20 member companies located in Beijing, Shanghai, Guangzhou, Nanjing, Chengdu and so on, whose main products includes TCM, Chemical medicine and Biological medicine, and the marketing network covers provinces, cities and autonomous regions all over the country. Followed concept of "Seeking progress all the time, safeguarding all human beings", by unremitting pursuit on the road of innovative development and benefiting people with high quantity, YRPG has gained sustainable, healthy and rapid growth. The Group has R&D platforms such as National enterprise technology center, National key laboratory of new technology of pharmaceutical preparation, and National engineering research center of TCM, and the under-construction new drug research institute of Jiangsu province (Yangtze River) focusing in research of new drug. YRPG has retained the No.1 with total count of golden prizes of QC achievements in national pharmaceutical industry for five years, and regarded as the single training base in domestic pharmaceutical industry by NICPBP (National Institute for the Control of Pharmaceutical and Biological Products). Since 1996 YRPG has gained No.1 comprehensive economic benefit in medical industry of Jiangsu province and in the national pharmaceutical industry forefront over 10 years since 1997. In 2010, the sales income was over RMB 25 billion.